VSee Health, Inc. Announces Postponement of Annual Meeting of Stockholders Until December 30, 2025

Rhea-AI Summary

VSee Health (NASDAQ:VSEE) announced it is postponing its 2025 Annual Meeting of Stockholders from December 15, 2025 at 2:30 p.m. ET to December 30, 2025 at 2:30 p.m. ET because it does not anticipate a quorum.

The meeting will be held via live webcast at https://www.cstproxy.com/vseehealth/2025. The record date remains November 20, 2025. Stockholders who already voted do not need to act; those who have not voted are encouraged to vote by December 29, 2025 at 11:59 p.m. ET. No proposal changes were made.

Key Figures

Original meeting date December 15, 2025, 2:30 p.m. ET Initial 2025 Annual Meeting schedule

New meeting date December 30, 2025, 2:30 p.m. ET Postponed 2025 Annual Meeting schedule

Record date November 20, 2025 Shareholders entitled to vote at Annual Meeting

Proxy filing date November 24, 2025 DEF 14A definitive proxy statement filing date

Voting deadline December 29, 2025, 11:59 p.m. ET Cutoff for shareholders to submit votes

Market Reality Check

$0.5161 Last Close

Volume Volume 2,023,600 vs 20-day average 1,285,438 (relative volume 1.57x) ahead of this governance update. high

Technical Price 0.5161 is trading below the 200-day moving average at 1, reflecting a longer-term downtrend.

Peers on Argus 1 Up

VSEE was down 0.97% while key peers like HCTI (-4.88%) and DRIO (-6.01%) also traded lower, but momentum scanner only flagged WORX up 5.46%, suggesting mixed, stock-specific moves rather than a clear sector-wide pattern.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Dec 04	Client webinar news	Neutral	+1.6%	Announcement of webinar sharing blueprint for scalable tele-urgent programs.
Nov 26	Private placement	Negative	-10.9%	Pricing of <b>$6.0M</b> at-the-market private placement with warrants.
Nov 25	Operations update	Positive	-6.8%	iDoc division contract progress and new hospital activations supporting revenue.
Nov 20	Leadership change	Positive	+6.7%	Appointment of Dr. Milton Chen as chairman to drive AI infrastructure growth.
Nov 17	Earnings update	Positive	-5.5%	Q3 2025 revenue growth and telehealth expansion alongside going-concern pressures.

Pattern Detected

Recent positive operating and growth updates have sometimes been followed by negative price reactions, while financing-related news has aligned with downside moves.

Recent Company History

Over the past month, VSEE reported Q3 2025 revenue growth to $3.98M and highlighted strong telehealth expansion and iDoc contract execution, yet shares fell after those updates. An AI-focused leadership change on Nov 20 saw a positive reaction, while a $6.0M private placement on Nov 26 coincided with a larger decline. This announcement about postponing the annual meeting ties back to the Nov 24 proxy process and ongoing efforts to secure sufficient shareholder participation for key governance proposals.

Market Pulse Summary

This announcement postpones VSEE’s 2025 Annual Meeting from December 15 to December 30, 2025 due to an anticipated lack of quorum, while keeping the November 20, 2025 record date and all proposals unchanged. It ties directly to the existing Schedule 14A proxy, which includes director elections, auditor ratification, and an equity incentive plan. Investors may track whether additional proxy solicitation successfully secures the votes needed to complete this governance agenda.

Key Terms

quorum regulatory

"it anticipates that it will not have a sufficient number of shares ... to constitute a quorum."

A quorum is the minimum number of members needed to officially hold a meeting or make decisions. It ensures that decisions are made with enough participation to represent the group’s interests, much like a majority must be present for a vote to be valid. For investors, understanding quorum is important because it affects when and how important company or organization decisions can be legally made.

proxy regulatory

"shares of the Company's common stock present in person or represented by proxy at the 2025 Annual Meeting"

A proxy is the authorization a shareholder gives to another person or document to cast votes on their behalf at a company meeting. Think of it like handing someone your voting ticket so they can represent your choices on board elections, executive pay, mergers and other big decisions; it matters because proxies determine who controls the company and which proposals pass, directly affecting share value and investor returns.

record date regulatory

"The close of business on November 20, 2025 will continue to be the record date"

The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.

definitive proxy statement regulatory

"read the Company's definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission"

A Definitive Proxy Statement is a detailed document that a company sends to its shareholders before a big meeting, like voting on important decisions. It explains what's being voted on and gives important information so shareholders can make informed choices. It matters because it helps shareholders understand and participate in key company decisions.

schedule 14a regulatory

"definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission"

Schedule 14A is a document that companies file with regulators to share important information with shareholders before a big vote, like approving a merger or election of directors. It matters because it helps investors understand what’s happening so they can make informed decisions about the company’s future.

AI-generated analysis. Not financial advice.

SAN JOSE, CALIFORNIA / ACCESS Newswire / December 12, 2025 / VSee Health, Inc. (NASDAQ:VSEE) a leader in innovative telemedicine solutions, today announced that it anticipates that it will not have a sufficient number of shares of the Company's common stock present in person or represented by proxy at the 2025 Annual Meeting of Stockholders (the "Annual Meeting"), scheduled for Monday, December 15, 2025 at 2:30 p.m. Eastern Time, to constitute a quorum. The Company has decided to postpone the Annual Meeting to 2:30 p.m. Eastern Time on December 30, 2025. The Annual Meeting will be conducted via live webcast at the following address:

https://www.cstproxy.com/vseehealth/2025.

The close of business on November 20, 2025 will continue to be the record date for the determination of stockholders of the Company entitled to vote at the Annual Meeting. Stockholders of the Company who have previously submitted their proxy or otherwise voted and who do not want to change their vote do not need to take any action.

No changes have been made in the proposals to be voted on by stockholders at the Annual Meeting. The Company encourages all of its stockholders to read the Company's definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission (the "SEC") on November 24, 2025 (the "Proxy Statement"), which is available free of charge on the SEC's website at www.sec.gov, and on the Company's website at https://vseehealth.com/investors/sec-filings.

The Company will continue to solicit votes from its stockholders with respect to the proposals set forth in the Proxy Statement. The Company encourages all stockholders who have not yet voted to do so before December 29, 2025 at 11:59 p.m., Eastern Time. Your vote is important regardless of how many shares you own. Voting as soon as possible will help us save on the costs associated with the Annual Meeting.

About VSee Health

VSee Health (NASDAQ:VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. The Company's offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and employers across the United States. For more information, please visit vseehealth.com.

Forward-Looking Statements

Matters discussed in this news release that are not statements of historical or current facts, including but not limited to those relating to VSee Health's ability to improve healthcare access and provider efficiencies, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements regarding the anticipated closing of the offering; the Company's anticipated use of proceeds from the offering; and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance or achievements to be materially different from historical results or from any future performance or achievements expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risk factors relating to VSee Health and its technology and billing services is included from time to time in the "Cautionary Note Regarding Forward-Looking Statements," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of VSee Health's periodic and current filings with the SEC, which are also made available on VSee Health's website at www.vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee Health undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.

Contact:

Anne Chang
VSee Health
media@vsee.com

VSee Investor Contact:

Milton Chen
VSee Health
investor@vsee.com

SOURCE: VSee Health

View the original press release on ACCESS Newswire

FAQ

Why did VSee (NASDAQ:VSEE) postpone its December 15, 2025 annual meeting?

The company said it does not anticipate having a sufficient number of shares present to constitute a quorum.

When and how will VSee's postponed 2025 annual meeting be held?

The meeting is rescheduled for December 30, 2025 at 2:30 p.m. ET and will be conducted via live webcast at https://www.cstproxy.com/vseehealth/2025.

What is the record date for VSee's 2025 annual meeting (VSEE)?

The record date remains November 20, 2025 for determining stockholders entitled to vote.

Do VSee shareholders who already voted need to take action after the postponement?

No. Shareholders who previously submitted a proxy or voted and do not want to change their vote do not need to take any action.

By what deadline should VSee (VSEE) shareholders vote for the rescheduled meeting?

The company encourages shareholders who have not yet voted to do so before December 29, 2025 at 11:59 p.m. ET.